Changes in microsomal activity in alcoholism and obesity

Alcoholism: Clinical and Experimental Research

Volumn 24, Issue 5, 2000, Pages 605-610

  De La Maza, M Pía ^a,b   Hirsch, Sandra ^a   Petermann, Margarita ^a   Suazo, Myriam ^a   Ugarte, Guillermo ^a   Bunout, Daniel ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b NONE   (Chile)

Author keywords

Alcoholic Liver Disease; Chlorzoxazone; CYP2E1; Microsomal Activity; Nonalcoholic Steatohepatitis; Obesity

Indexed keywords

ALCOHOL; CHLORZOXAZONE; DIMETHYLNITROSAMINE DEMETHYLASE;

ALCOHOL LIVER DISEASE; ALCOHOLISM; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME INDUCTION; HUMAN; HYDROXYLATION; LIVER HISTOLOGY; LIVER INJURY; MALE; MICROSOME; OBESITY; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0034076405     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000374-200005000-00004     Document Type: Article

References (44)

1. Albano E, Clot P, Morimoto M, Tomasi A, Ingelman-Sundberg M, French S (1996). Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol. Hepatology 23:155-163.
2. Albano E, Tomasi A, Persson JO, Terelius Y, Goria-Gatti L, Ingelman-Sundberg M, Dianzani MU (1991) Role of ethanol-inducible cytochrome P450 (P450IIE1) in catalysing the free radical activation of aliphatic alcohols. Biochem Pharmacol 41:1895-1902.
3. Baptista A, Bianchi L, DeGroote J. (1981) Alcoholic liver disease: Morphologic manifestations. Lancet 1:707-710.
4. Bunout D, Gattás V, Iturriaga H, Pérez C, Pereda T, Ugarte G (1983). Nutritional status of alcoholic patients: Its possible relationship to alcoholic liver damage. Am J Clin Nutr 38:469-473.
5. Castillo T, Koop DR, Kamimura S, Triadafilopoulos G, Tsukamoto H (1995). Role of cytochrome P-450 2E1 in ethanol-, carbon tetrachloride-and iron-dependent microsomal lipid peroxidation. Hepatology 16:992-996.
6. Cohen PA, Mak KM, Rosman AS, Kessova I, Mishin VM, Koivisto T, Lieber CS (1997) Immunohistochemical determination of hepatic cytochrome P-4502E1 in formalin-fixed, paraffin-embedded sections. Alcohol Clin Exp Res 21:1057-1062.
7. Dallongeville J, Marécaux N, Ducimetière P, Ferrières J, Arveiler D, Bingham A, Ruidavets JB, Simon C, Amouyel P (1998). Influence of alcohol consumption and various beverages on waist girth and waist-to-hip ratio in a sample of French men and women. Int J Obes 22:1178-1183.
8. Davidson CS (1981) Natural history of alcoholic liver disease. Sem Liver Dis 1:173-178.
9. Dilger K, Metzler J, Bode JC, Klotz U (1997). CYP2E1 activity in patients with alcoholic liver disease. J Hepatol 27:1009-1014.
10. Durnin JVGA, Womersley J (1974). Body fat assessment from total body density and its estimation from skinfold thickness: Measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32:77-96.
11. Ekstrom G, Ingelman-Sundberg M (1989) Rat microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P450IIE1). Biochem Pharmacol 38:1313-1319.
12. Ekstrom G, Von Bahr C, Ingelman-Sundberg M (1989) Human liver microsomal cytochrome P-450IIE1: Immunological evaluation of its contribution to microsomal ethanol oxidation, carbon tetrachloride reduction and NADPH oxidase activity. Biochem Pharmacol 38:689-693.
13. Girré C, Lucas D, Hispard E, Ménez C, Dally S, Mènez JF (1994) Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. Biochem Pharmacol 47:1503-1508.
14. Hirsch S, De la Maza MP, Petermann M, Bunout D (1998). Lipid turnover in alcoholics before and after an ethanol load. Nutrition 14:437-442.
15. Hong J, Pan J, Gonzalez FJ, Gelboin HV, Yang CS (1987) The induction of a specific form of cytochrome P-450 (P450j) by fasting. Biochem Biophys Res Commun 142:1077-1083.
16. Ishii H (1996) Oxidative stress in alcoholic liver injury. Alcohol Clin Exp Res (Suppl 8) 20:162A-167A.
17. Iturriaga H, Bunout D, Hirsch S, Ugarte G (1988). Overweight as a risk factor or a predictive sign of histological liver damage in alcoholics. Am J Clin Nutr 47:235-238.
18. Iturriaga H, Kelly M, Bunout D, Pino ME, Pereda T, Barrera R, Petermann M, Ugarte G (1986) Glucose tolerance and the insulin response in recently drinking alcoholic patients: Possible effects of withdrawal. Metabolism 35:238-243.
19. Iturriaga H, Hirsch S, Bunout D, Diaz M, Kelly M, Silva G, de la Maza MP, Petermann M, Ugarte G (1993) Prediction of histological liver damage in asymptomatic alcoholic patients by means of clinical and laboratory data. Rev Med Chile 121:369-378.
20. Kamimura S, Gaal K, Britton R, Bacon BR, Triadafilopoulos G, Tsukamoto H (1992). Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: Association of lipid peroxidation with liver fibrogenesis. Hepatology 16:448-453.
21. Kharasch DE, Thummel KE, Mhyre J, Lillibridge JH (1993) Single dose disulfiram inhibition of chlorzoxazone metabolism: A clinical probe for P450 2E1. Clin Pharmacol Ther 53:643-650.
22. Leinonen J, Lehtimaki T, Toyokuni S, Okada K, Tanaka T, Hiai H, Ochi H, Laippala P, Rantalaiho V, Wirta O, Pasternack A, Alho H (1997) New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 417:150-152.
23. Lettéron P, Duchatelle V, Berson A, Fromenty B, Fisch C, Deggot C, Benhamou JP (1993) Increased ethane exhalation, an in vivo index of lipid peroxidation, in alcohol-abusers. Gut 34:409-414.
24. Lieber CS, De Carli LM (1968) Ethanol oxidation by hepatic microsomes. Adaptative increase after ethanol feeding. Science (Wash. DC) 162: 690-691.
25. Lucas D, Berthou F, Dréano Y, Lozac'h P, Volant A, Ménez JF (1993a) Comparison of levels of cytochromes P-450, CYP1A2, CYP2E1, and their related monooxygenase activities in human surgical liver samples. Alcohol Clin Exp Res 17:900-905.
26. Lucas D, Berthou F, Girre C, Poitrenand F, Menez JF (1993b) High performance liquid chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in serum: A tool for indirect evaluation of cytochrome P4502E1 activity in humans. J Chromatogr 622:79-86.
27. Morimoto M, Hagbjork AL, Wan YJ, Fu PC, Clot P, Albano E, Ingelman-Sundberg N, French SW (1995) Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibitors. Hepatology 21:1610-1617.
28. Nanji A, French SW (1986) Dietary factors and alcoholic cirrhosis. Alcohol Clin Exp Res 10:271-273.
29. Nanji A, Mendenhall CL, French SW (1989) Beef fat prevents alcoholic liver disease in rat. Alcohol Clin Exp Res 13:15-19.
30. Nanji A, Sadrzadeh SMH, Yang EK, Fogt F, Meydani M, Dannenberg AJ (1995) Dietary saturated fatty acids: A novel treatment for alcoholic liver disease. Gastroenterology 109:547-554.
31. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC (1997) Excess weight risk factor for alcoholic liver disease. Hepatology 25:108-111.
32. O'Shea D, Davis SN, Kim RB, Wilkinson GR (1994) Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: A putative probe of CYP2E1 activity. Clin Pharmacol Ther 56:359-367.
33. Perrot N, Nalpas B, Yang CS, Beaune PH (1989) Modulation of cytochrome P 450 isozymes in human liver by ethanol and drug intake. Eur J Clin Invest 9:549-555.
34. Raucy JL, Lasker JM, Kraner JC, Salazar DE, Lieber CS, Corcoran GB (1991) Induction of cytochrome P450IIE1 in the obese overfed rat. Mol Pharmacol 39:275-280.
35. Song BJ (1996) Ethanol-inducible cytochrome P450 (CYP2E1): Biochemistry, molecular biology and clinical relevance:1996 update. Alcohol Clin Exp Res (Suppl 8) 20:138A-146A.
36. Suter PM, Schultz Y, Jequier E (1992). The effect of ethanol on fat storage in healthy subjects. N Engl J Med 326:983-987.
37. Teli MR, James OFW, Burt AD, Bennet MK, Day CP (1995) The natural history of nonalcohol fatty liver: A follow-up study. Hepatology 22: 1714-1719.
38. Tsukamoto H, Towner SJ, Ciofalo LM, French SW (1986) Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology 6:814-822.
39. Tsutsumi M, Lasker J, Shimizu M, Rosman A, Lieber CS (1989) The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver. Hepatology 10:437-446.
40. Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C (1998). Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 27:128-133.
41. Weltman MD, Farrell GC, Liddle C (1996). Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 111:1645-1653.
42. Woodcroft KJ, Novak RF (1997) Insulin effects on CYP2E1, 2B, 3A, and 4A expression in primary cultured rat hepatocytes. Chem Biol Interact 107:75-91.
43. Yoo-J-SH, Ning SM, Pantuck CB, Pantuck EJ, Yang CS (1991) Regulation of hepatic microsomal cytochrome P450IIE1 by dietary lipids and carbohydrates in rats. J Nutr 121:959-965.
44. Zand R, Nelson SD, Slattery JT, Thummel Ke, Kalhorn TF, Adams SP, Wright JM (1993) Inhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humans. Clin Pharmacol Ther 54: 142-149.